Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease (Q28588314)

31 January 2017

title

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease (English)

1 reference

31 January 2017

0 references

1 reference

GOA release 2020-03-11

author name string

A. Yamamoto

series ordinal

1

1 reference

31 January 2017

J. J. Lucas

series ordinal

2

1 reference

31 January 2017

R. Hen

series ordinal

3

1 reference

31 January 2017

language of work or name

English

0 references

publication date

31 March 2000

1 reference

31 January 2017

1 reference

31 January 2017

volume

101

1 reference

31 January 2017

issue

1

1 reference

31 January 2017

page(s)

57–66

1 reference

Ubiquitin, cellular inclusions and their role in neurodegeneration

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Co-regulation of two gene activities by tetracycline via a bidirectional promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Inactivation of the mouse Huntington's disease gene homolog Hdh

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Use of tetracycline-controlled gene expression systems to study mammalian cell cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Trinucleotide instability: a repeating theme in human inherited disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Regional specificity of brain atrophy in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Structural neurology: are seeds at the root of neuronal degeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Huntington's disease. Pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Control of memory formation through regulated expression of a CaMKII transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Reactive astrocytes: cellular and molecular cues to biological function

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Impaired synaptic plasticity in mice carrying the Huntington's disease mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

1 reference

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Homozygotes for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980623-6

7 January 2021

10.1016/S0092-8674(00)80623-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017